US 12281083
2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof
granted A61KA61K31/4184A61K31/422
Quick answer
US patent 12281083 (2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof) held by PTC THERAPEUTICS, INC. expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4184, A61K31/422, A61K31/427, A61K31/4439